Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AOC3 | Q16853 | 11/20 | 0.56 |
| ▸ | ITGB3 | P05106 | 8/20 | 0.55 |
| ▸ | ITGA2B | P08514 | 8/20 | 0.55 |
| ▸ | GRM5 | P41594 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21780095 | 0.83 | AOC3 (0.72) | AOC3ITGB3ITGA2B | |
| SCHEMBL21780109 | 0.81 | ITGB3 (0.44) | AOC3ITGB3ITGA2B | |
| SCHEMBL21845102 | 0.80 | AOC3 (0.70) | AOC3ITGB3ITGA2B | |
| SCHEMBL29438690 | 0.79 | GRM5 (0.62) | ITGB3ITGA2BGRM5 | |
| SCHEMBL4502402 | 0.79 | GRM5 (0.62) | ITGB3ITGA2BGRM5 | |
| SCHEMBL21845054 | 0.78 | AOC3 (0.49) | AOC3ITGB3ITGA2B | |
| SCHEMBL8544909 | 0.78 | ITGB3 (0.54) | AOC3ITGB3ITGA2BGRM5 | |
| SCHEMBL25260183 | 0.77 | LMNA (0.64) | AOC3ITGB3ITGA2BGRM5 | |
| SCHEMBL8549552 | 0.77 | AOC3 (0.54) | AOC3ITGB3ITGA2BGRM5 | |
| SCHEMBL27706520 | 0.77 | GRM5 (0.57) | AOC3ITGB3ITGA2BGRM5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200087248-A1 | Fluoroallylamine Derivative And Use Thereof | SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD. (CN) | 2020-03-19 | — | — | US | disclosed |
| EP-3617186-A1 | FLUOROALLYLAMINE DERIVATIVE AND USE THEREOF | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (CN) | 2020-03-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200087248-A1 | Fluoroallylamine Derivative And Use Thereof | VAPB, VAPA, SLC28A1 | AOC3 6/4885ITGB3 1505/4885ITGA2B 2050/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.